Cited 13 time in
Effects of analgesics and antidepressants on TREK-2 and TRESK currents
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, Hyun | - |
| dc.contributor.author | Kim, Eun-Jin | - |
| dc.contributor.author | Han, Jaehee | - |
| dc.contributor.author | Han, Jongwoo | - |
| dc.contributor.author | Kang, Dawon | - |
| dc.date.accessioned | 2022-12-26T20:05:29Z | - |
| dc.date.available | 2022-12-26T20:05:29Z | - |
| dc.date.issued | 2016-07 | - |
| dc.identifier.issn | 1226-4512 | - |
| dc.identifier.issn | 2093-3827 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/15407 | - |
| dc.description.abstract | TWIK-related K+ channel-2 (TREK-2) and TWIK-related spinal cord K+ (TRESK) channel are members of two-pore domain K+ channel family. They are well expressed and help to set the resting membrane potential in sensory neurons. Modulation of TREK-2 and TRESK channels are involved in the pathogenesis of pain, and specific activators of TREK-2 and TRESK may be beneficial for the treatment of pain symptoms. However, the effect of commonly used analgesics on TREK-2 and TRESK channels are not known. Here, we investigated the effect of analgesics on TREK-2 and TRESK channels. The effects of analgesics were examined in HEK cells transfected with TREK-2 or TRESK. Amitriptyline, citalopram, escitalopram, and fluoxetine significantly inhibited TREK-2 and TRESK currents in HEK cells (p<0.05, n=10). Acetaminophen, ibuprofen, nabumetone, and bupropion inhibited TRESK, but had no effect on TREK-2. These results show that all analgesics tested in this study inhibit TRESK activity. Further study is needed to identify the mechanisms by which the analgesics modulate TREK-2 and TRESK differently. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY | - |
| dc.title | Effects of analgesics and antidepressants on TREK-2 and TRESK currents | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.4196/kjpp.2016.20.4.379 | - |
| dc.identifier.scopusid | 2-s2.0-84978983193 | - |
| dc.identifier.wosid | 000378860300007 | - |
| dc.identifier.bibliographicCitation | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, v.20, no.4, pp 379 - 385 | - |
| dc.citation.title | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY | - |
| dc.citation.volume | 20 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 379 | - |
| dc.citation.endPage | 385 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART002124892 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalResearchArea | Physiology | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Physiology | - |
| dc.subject.keywordPlus | POTASSIUM CHANNEL | - |
| dc.subject.keywordPlus | NEUROPATHIC PAIN | - |
| dc.subject.keywordPlus | INHIBITION | - |
| dc.subject.keywordPlus | FLUOXETINE | - |
| dc.subject.keywordPlus | DEPRESSION | - |
| dc.subject.keywordPlus | MIGRAINE | - |
| dc.subject.keywordPlus | AMITRIPTYLINE | - |
| dc.subject.keywordPlus | ACTIVATION | - |
| dc.subject.keywordPlus | EXPRESSION | - |
| dc.subject.keywordPlus | BUPROPION | - |
| dc.subject.keywordAuthor | Analgesics | - |
| dc.subject.keywordAuthor | Background potassium channels | - |
| dc.subject.keywordAuthor | Pain | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
